Raloxifene adjunctive therapy for postmenopausal women suffering from chronic schizophrenia: a randomized double-blind and placebo controlled trial

BACKGROUND: Cumulative evidence from epidemiological, preclinical and clinical studies suggests estrogens may have psychoprotective effects in schizophrenic patients. Selective Estrogen Receptor Modulators could have therapeutic benefits in schizophrenia for both sexes without being hazardous to gyn...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Kianimehr, Gilda, Fatehi, Farzad, Hashempoor, Sara, Khodaei-Ardakani, Mohammad-Reza, Rezaei, Farzin, Nazari, Ali, Kashani, Ladan, Akhondzadeh, Shahin
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2014
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4100751/
https://ncbi.nlm.nih.gov/pubmed/25012765
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/2008-2231-22-55
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados